Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP472676.RAV_g0YTN5G3ep0a9_mQMqa2o3kqCBIVZqb0utR_oikSU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP472676.RAV_g0YTN5G3ep0a9_mQMqa2o3kqCBIVZqb0utR_oikSU130_assertion type Assertion NP472676.RAV_g0YTN5G3ep0a9_mQMqa2o3kqCBIVZqb0utR_oikSU130_head.
- NP472676.RAV_g0YTN5G3ep0a9_mQMqa2o3kqCBIVZqb0utR_oikSU130_assertion description "[Allelic frequencies in 70 controls and 110 patients with diabetes from the Chennai Urban Population Study were 52.9% for FABP2 Thr54, 73.0% for APOC3 -482T, and 80.2% for APOC3 -455C.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472676.RAV_g0YTN5G3ep0a9_mQMqa2o3kqCBIVZqb0utR_oikSU130_provenance.
- NP472676.RAV_g0YTN5G3ep0a9_mQMqa2o3kqCBIVZqb0utR_oikSU130_assertion evidence source_evidence_literature NP472676.RAV_g0YTN5G3ep0a9_mQMqa2o3kqCBIVZqb0utR_oikSU130_provenance.
- NP472676.RAV_g0YTN5G3ep0a9_mQMqa2o3kqCBIVZqb0utR_oikSU130_assertion SIO_000772 15598690 NP472676.RAV_g0YTN5G3ep0a9_mQMqa2o3kqCBIVZqb0utR_oikSU130_provenance.
- NP472676.RAV_g0YTN5G3ep0a9_mQMqa2o3kqCBIVZqb0utR_oikSU130_assertion wasDerivedFrom befree-2016 NP472676.RAV_g0YTN5G3ep0a9_mQMqa2o3kqCBIVZqb0utR_oikSU130_provenance.
- NP472676.RAV_g0YTN5G3ep0a9_mQMqa2o3kqCBIVZqb0utR_oikSU130_assertion wasGeneratedBy ECO_0000203 NP472676.RAV_g0YTN5G3ep0a9_mQMqa2o3kqCBIVZqb0utR_oikSU130_provenance.